Clinical Trials on Vascular Graft Infection in Belgium

Total 2977 results

GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults

Pneumococcal Disease

Belgium
Pfizer

Completed

Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. (AS@WORK)

Ankylosing Spondylitis

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

Ankylosing Spondylitis

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
Ziekenhuis Oost-Limburg

Completed

Time Gain in the Diagnosis Myocardial Infarction by Troponin Point of Care Testing in the Emergency Room (T-POCT)

Angina, Stable | Angina Pectoris | Angina, Unstable | Non STEMI | Angina, Prinzmetal's

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System

Peripheral Vascular Disease

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
University Ghent
Merck Sharp & Dohme LLC; the Flanders Institute for Biotechnology

Completed

Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation (GO-GUT)

Axial Spondyloarthritis

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
ANRS, Emerging Infectious Diseases

Completed

Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients (ANRS ECHAM)

HIV Infection | Liver Injuries

France, Germany, Belgium
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
ANRS, Emerging Infectious Diseases
INSERM SC10-US19

Recruiting

Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load (SYNACTHIV)

HIV-1-infection, Subtype b

Belgium, France
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients

Gram-Positive Bacterial Infections

Belgium
GlaxoSmithKline

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

Hepatitis B

Belgium
University Hospital, Ghent
Hoffmann-La Roche

Completed

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Cytomegalovirus Infections

Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect

Pulmonary Vascular Disease

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

Pulmonary Tuberculosis

Belgium
GlaxoSmithKline

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

Hepatitis B

Belgium
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

Graft Rejection

United Kingdom, Canada, Taiwan, United States, France, Belgium, Spain, Australia, Germany, New Zealand, Argentina, Italy, Austria, Norway, Puerto Rico
GlaxoSmithKline
Region of Wallonia; Public Private Partnership with Institute for Medical Immunology...

Completed

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Hepatitis B

Belgium
Institute of Tropical Medicine, Belgium
Sciensano; Military Hospital, Brussels

Completed

Simplifying the Rabies Pre-exposure Vaccination

Rabies

Belgium
University Ghent
University Hospital, Ghent

Terminated

tDCS and Aphasia Therapy in the Chronic Phase After Stroke

Aphasia Following Cerebral Infarction | Aphasia Following Nontraumatic Intracerebral Hemorrhage

Belgium
Institute of Tropical Medicine, Belgium
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique... and other collaborators

Completed

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres (IDIS)

Fever | Salmonella Infections | Blood Stream Infections | Salmonella Septicemia | Parasitic Infections

Belgium, Cambodia, Congo, The Democratic Republic of the
GlaxoSmithKline

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Whooping Cough

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
Vrije Universiteit Brussel
University Hospital, Antwerp; Universiteit Antwerpen; Artesis University College...

Completed

Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome

Chronic Fatigue Syndrome

Belgium
Janssen Research & Development, LLC

Completed

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (INSIGHT)

Hepatitis B

France, United States, Belgium, United Kingdom, Poland, New Zealand, Germany, Italy, Canada
Flanders Medical Research Program

Completed

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (ROBINSON)

Peripheral Vascular Disease

Belgium
Sciensano

Completed

COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities

COVID-19

Belgium
Cliniques universitaires Saint-Luc- Université...
Society for Anesthesia and Resuscitation of Belgium

Completed

Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals (COVID)

COVID-19

Belgium
University Hospital, Ghent
UCB Pharma

Withdrawn

Sodium Oxybate in Patients With Chronic Fatigue Syndrome.

Chronic Fatigue Syndrome

Belgium
KU Leuven

Completed

Recognition of Serious Infections in the Elderly (ROSIE)

Infection

Belgium
University Ghent

Recruiting

PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry (PROSPECT)

Vascular Diseases

Belgium, Denmark
ID3 Medical
CyndRx, LLC

Completed

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
Spectranetics Corporation

Completed

ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study (MODIFY)

Peripheral Arterial Disease

Belgium
Brugmann University Hospital

Completed

Prevalence and Screening of Hepatitis C in Belgium in 2015

Hepatitis C

Belgium

3

Subscribe